BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31564475)

  • 1. Nomogram for predicting gastric cancer recurrence using biomarker gene expression.
    Jeong SH; Kim RB; Park SY; Park J; Jung EJ; Ju YT; Jeong CY; Park M; Ko GH; Song DH; Koh HM; Kim WH; Yang HK; Lee YJ; Hong SC
    Eur J Surg Oncol; 2020 Jan; 46(1):195-201. PubMed ID: 31564475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
    Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
    World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a nomogram for preoperative prediction of lymph node metastasis in early gastric cancer.
    Yin XY; Pang T; Liu Y; Cui HT; Luo TH; Lu ZM; Xue XC; Fang GE
    World J Surg Oncol; 2020 Jan; 18(1):2. PubMed ID: 31898548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
    Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
    Zhang Z; Dong Y; Hua J; Xue H; Hu J; Jiang T; Shi L; Du J
    Gene; 2019 May; 699():125-134. PubMed ID: 30849543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
    Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
    Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection.
    He Y; Mao M; Shi W; He Z; Zhang L; Wang X
    J Transl Med; 2019 Mar; 17(1):98. PubMed ID: 30909980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
    BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram to predict prolonged postoperative ileus after gastrectomy in gastric cancer.
    Liang WQ; Zhang KC; Cui JX; Xi HQ; Cai AZ; Li JY; Liu YH; Liu J; Zhang W; Wang PP; Wei B; Chen L
    World J Gastroenterol; 2019 Oct; 25(38):5838-5849. PubMed ID: 31636476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer.
    Wang W; Sun Z; Deng JY; Qi XL; Feng XY; Fang C; Ma XH; Wang ZN; Liang H; Xu HM; Zhou ZW
    Cancer Commun (Lond); 2018 May; 38(1):23. PubMed ID: 29764518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
    Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
    J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
    Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
    Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer.
    Lee SB; Kim J; Sohn G; Kim J; Chung IY; Kim HJ; Ko BS; Son BH; Ahn SH; Lee JW; Jung KH
    Cancer Res Treat; 2019 Jul; 51(3):1073-1085. PubMed ID: 30384581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.
    Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T
    Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.